{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:40:46Z","timestamp":1791841246037,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002985","name":"Delhi Technological University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002985","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lfs.2021.119908","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T10:47:29Z","timestamp":1629888449000},"page":"119908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Applications of CRISPR as a potential therapeutic"],"prefix":"10.1016","volume":"284","author":[{"given":"Ritika","family":"Luthra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriti","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119908_bb0005","first-page":"90","article-title":"Focus: genome editing: genome editing: past, present, and future","volume":"653","author":"Dana","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2021.119908_bb0010","first-page":"76","article-title":"Different strategies of gene delivery for treatment of cancer and other disorders","volume":"6","author":"Elnaz","year":"2016","journal-title":"J. Solid Tumors"},{"key":"10.1016\/j.lfs.2021.119908_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.119908_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2174\/1566523215666150929110424","article-title":"Contemporary animal models for human gene therapy applications","volume":"15","author":"Chitra","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.lfs.2021.119908_bb0025","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nakata nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.lfs.2021.119908_bb0030","article-title":"CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine","author":"Kampmann","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.lfs.2021.119908_bb0035","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.lfs.2021.119908_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sbi.2016.11.013","article-title":"Structures and mechanisms of CRISPR RNA-guided effector nucleases","volume":"43","author":"Nishimasu","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.lfs.2021.119908_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrmicro.2016.184","article-title":"Diversity and evolution of class 2 CRISPR\u2013Cas systems","volume":"15","author":"Shmakov","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2021.119908_bb0050","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2021.119908_bb0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2016.11.040","article-title":"C2c1-sgRNA complex structure reveals RNA-guided DNA cleavage mechanism","volume":"65","author":"Liu","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2021.119908_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111007","article-title":"CRISPR technology: the engine that drives cancer therapy","volume":"133","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2021.119908_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"Charpentier a programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.lfs.2021.119908_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.1179555","article-title":"Barrangou CRISPR\/Cas, the immune system of bacteria and archaea","volume":"327","author":"Horvath","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.lfs.2021.119908_bb0075","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nsmb.3486","article-title":"Class2 CRISPR-cas RNA-guided endonucleases: Swiss army knives of genome editing","volume":"24","author":"Stella","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.119908_bb0080","doi-asserted-by":"crossref","first-page":"20150496","DOI":"10.1098\/rstb.2015.0496","article-title":"CRISPR-cas: biology, mechanisms and relevance","volume":"371","author":"Hille","year":"2016","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.lfs.2021.119908_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119908_bb0090","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JB.01412-07","article-title":"Phage response to CRISPR-encoded resistance in Streptococcus thermophilus","volume":"190","author":"Deveau","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.lfs.2021.119908_bb0095","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","article-title":"Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.119908_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.31486\/toj.18.0076","article-title":"Sickle cell disease: advances in treatment","volume":"18","author":"Gardner","year":"2018","journal-title":"Ochsner J."},{"key":"10.1016\/j.lfs.2021.119908_bb0105","series-title":"Future Possibilities, and Challenges","first-page":"37","article-title":"CRISPR\/Cas9 for sickle cell disease: applications","author":"Demirci","year":"2019"},{"key":"10.1016\/j.lfs.2021.119908_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u00df-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.119908_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2021.119908_bb0120","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1182\/blood.V122.21.1022.1022","article-title":"Targeting BCL11A and KLF1 for the treatment of sickle cell disease and \u00df-thalassemia in vitro using antisense oligonucleotides","volume":"122","author":"Peralta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2021.119908_bb0125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-mediated correction of the sickle mutation in human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2021.119908_bb0130","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMcibr1809628","article-title":"Hemoglobinopathies in the fetal position","volume":"379","author":"Pasricha","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.119908_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100588","article-title":"Challenges of blood transfusions in \u00df-thalassemia","volume":"37","author":"Shah","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.lfs.2021.119908_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100464","article-title":"CRISPR\/Cas9-mediated \u00df-globin gene knockout in rabbits recapitulates human \u00df-thalassemia","volume":"296","author":"Yang","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119908_bb0145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omtm.2021.03.025","article-title":"Efficient CRISPR-Cas9-based genome editing of \u00df-globin gene on erythroid cells from homozygous \u00df039-thalassemia patients","volume":"21","author":"Cosenza","year":"2021","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.lfs.2021.119908_bb0150","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.7150\/thno.43360","article-title":"Advances in CRISPR\/Cas-based gene therapy in human genetic diseases","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics."},{"key":"10.1016\/j.lfs.2021.119908_bb0155","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.10-2077","article-title":"Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment","volume":"139","author":"Rogan","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2021.119908_bb0160","doi-asserted-by":"crossref","first-page":"eaav8375","DOI":"10.1126\/scitranslmed.aav8375","article-title":"In utero gene editing for monogenic lung disease","volume":"11","author":"Alapati","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2021.119908_bb0165","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2015.07.062","article-title":"Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs","volume":"12","author":"Firth","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.omtn.2019.02.006","article-title":"Efficient gene editing at major CFTR mutation loci","volume":"16","author":"Ruan","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.lfs.2021.119908_bb0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2018.04.001","article-title":"CRISPR\/Cas9 for cancer research and therapy","volume":"55","author":"Zhan","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2021.119908_bb0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature.2016.20988","article-title":"CRISPR gene-editing tested in a person for the first time","volume":"539","author":"Cyranoski","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119908_bb0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/scitranslmed.aao3240","article-title":"CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors","volume":"10","author":"Reinshagen","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"7550","key":"10.1016\/j.lfs.2021.119908_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature14415","article-title":"Sequential cancer mutations in cultured human intestinal stem cells","volume":"521","author":"Drost","year":"2015","journal-title":"Nature"},{"issue":"7664","key":"10.1016\/j.lfs.2021.119908_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.lfs.2021.119908_bb0200","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41375-018-0065-5","article-title":"An \"off-the-shelf\" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies","volume":"32","author":"Cooper","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.lfs.2021.119908_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw183","article-title":"Inactivation of cancer mutations utilizing CRISPR\/Cas9","volume":"109","author":"Gebler","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2021.119908_bb0210","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2021.119908_bb0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep4.1315","article-title":"<i>Ex Vivo<\/i> hepatocyte reprograming promotes homology-directed DNA repair to correct metabolic disease in mice after transplantation","volume":"3","author":"VanLith","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.lfs.2021.119908_bb0220","doi-asserted-by":"crossref","first-page":"12642","DOI":"10.1038\/ncomms12642","article-title":"Reprogramming metabolic pathways in vivo with CRISPR\/Cas9 genome editing to treat hereditary tyrosinaemia","volume":"7","author":"Pankowicz","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.119908_bb0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2018.11","article-title":"CRISPR\u2013Cas-related technologies in basic and translational liver research","volume":"15","author":"Song","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2021.119908_bb0230","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ymthe.2020.11.023","article-title":"CRISPR\/Cas9-mediated gene correction in newborn rabbits with hereditary tyrosinemia type I","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2021.119908_bb0235","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: current management and clinical trials","author":"Daich Varela","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.lfs.2021.119908_bb0240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic gene editing of GUCY2D by AAV-CRISPR\/Cas9 alters retinal structure and function in mouse and macaque","volume":"30","author":"McCullough","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.lfs.2021.119908_bb0245","doi-asserted-by":"crossref","first-page":"eaba5614","DOI":"10.1126\/sciadv.aba5614","article-title":"A gene therapy for inherited blindness using dCas9-VPR\u2013mediated transcriptional activation","volume":"6","author":"B\u00f6hm","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2021.119908_bb0250","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(17)30377-0","article-title":"Corrections","volume":"16","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2021.119908_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118165","article-title":"CRISPR\/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases","volume":"259","author":"Karimian","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.119908_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JHD-170266","article-title":"'Inhibition of TRPC1 - dependent store-operated calcium entry improves synaptic stability and motor performance in a mouse model of Huntington\u2019s disease","volume":"7","author":"Jun","year":"2018","journal-title":"J. Huntington's Dis."},{"key":"10.1016\/j.lfs.2021.119908_bb0265","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/ijms18040754","article-title":"CRISPR -Cas9 mediated gene -silencing of the mutant huntingtin gene in an in vitro model of Huntington\u2019s disease","volume":"18","author":"Kolli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119908_bb0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/hgtb.2018.187","article-title":"Development of CRISPR-mediated Systems in the Study of duchenne muscular dystrophy","volume":"30","author":"Cai","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.lfs.2021.119908_bb0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science (80-. )"},{"key":"10.1016\/j.lfs.2021.119908_bb0280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science (80-. )"},{"key":"10.1016\/j.lfs.2021.119908_bb0285","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science (80-. )"},{"key":"10.1016\/j.lfs.2021.119908_bb0290","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.lfs.2021.119908_bb0295","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2021.119908_bb0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-019-1430-x","article-title":"A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene","volume":"572","author":"Kemaladewi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119908_bb0305","doi-asserted-by":"crossref","first-page":"37051","DOI":"10.1038\/srep37051","article-title":"Adenoviral vectors encoding CRISPR\/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells","volume":"6","author":"Maggio","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0310","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","article-title":"Functional Rescue of Dystrophin Deficiency in mice caused by frameshift mutations using campylobacter jejuni Cas9","volume":"26","author":"Koo","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2021.119908_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2021.119908_bb0320","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2021.119908_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2021.04.002","article-title":"CRISPR technologies for the treatment of Duchenne muscular dystrophy","author":"Choi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2021.119908_bb0330","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.lfs.2021.119908_bb0335","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/603985","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells","volume":"2014","author":"Hu","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2021.119908_bb0345","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","volume":"6","author":"Liao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.119908_bb0350","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.virusres.2017.07.020","article-title":"CRISPR-cas based antiviral strategies against HIV-1","volume":"244","author":"Wang","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.lfs.2021.119908_bb0355","doi-asserted-by":"crossref","first-page":"41968","DOI":"10.1038\/srep41968","article-title":"A combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape","volume":"7","author":"Lebbink","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0360","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.lfs.2021.119908_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00069","article-title":"Application of CRISPR\/Cas9-based gene editing in HIV-1\/AIDS therapy","volume":"9","author":"Xiao","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2021.119908_bb0370","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s15010-020-01554-w","article-title":"CRISPR-based strategies in infectious disease diagnosis and therapy","volume":"49","author":"Binnie","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.lfs.2021.119908_bb0375","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0380","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.omtn.2020.03.005","article-title":"Permanent inactivation of HBV genomes by CRISPR\/Cas9-mediated non-cleavage base editing","volume":"20","author":"Yang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.lfs.2021.119908_bb0385","doi-asserted-by":"crossref","first-page":"34531","DOI":"10.1038\/srep34531","article-title":"Increasing the efficiency of CRISPR\/Cas9-mediated precise genome editing of HSV-1 virus in human cells","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2021.119908_bb0395","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2021.119908_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/603985","article-title":"Disruption of HPV16-E7 by CRISPR\/cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells","volume":"2014","author":"Hu","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2021.119908_bb0405","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.119908_bb0410","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1128\/JVI.00060-16","article-title":"Highly efficient CRISPR\/Cas9-mediated cloning and functional characterization of gastric cancer-derived Epstein-Barr virus strains","volume":"90","author":"Kanda","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2021.119908_bb0415","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virusres.2017.04.019","article-title":"Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9","volume":"244","author":"Yuen","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.lfs.2021.119908_bb0420","doi-asserted-by":"crossref","first-page":"36921","DOI":"10.1038\/srep36921","article-title":"Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR\/Cas9","volume":"6","author":"Chou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0425","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2021.119908_bb0430","first-page":"860","article-title":"Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection","volume":"26","author":"Wang","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.lfs.2021.119908_bb0435","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.scib.2020.04.041","article-title":"Rapid and sensitive detection of COVID-19 using CRISPR\/Cas12a-based detection with naked eye readout, CRISPR\/Cas12a-NER","volume":"65","author":"Wang","year":"2020","journal-title":"Sci. Bull."},{"key":"10.1016\/j.lfs.2021.119908_bb0440","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-981-13-8367-0_12","article-title":"Advances towards therapeutic approaches for mtDNA disease","volume":"1158","author":"Al Khatib","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119908_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23561-7","article-title":"Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo","volume":"12","author":"Zekonyte","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.lfs.2021.119908_bb0450","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2015.126","article-title":"MitoTALEN: a general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases","volume":"23","author":"Hashimoto","year":"2015","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2021.119908_bb0455","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acssynbio.8b00411","article-title":"Knock-in strategy for editing human and zebrafish mitochondrial DNA using Mito-CRISPR\/Cas9 system","volume":"8","author":"Bian","year":"2019","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.lfs.2021.119908_bb0460","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","article-title":"A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing","volume":"583","author":"Mok","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119908_bb0465","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10565-020-09549-x","article-title":"New potentials of mitochondrial DNA editing","volume":"36","author":"Wang","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.lfs.2021.119908_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.627050","article-title":"Adapting CRISPR\/Cas9 system for targeting mitochondrial genome","volume":"12","author":"Hussain","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2021.119908_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/305716","article-title":"Efficient mitochondrial genome editing by CRISPR\/Cas9","volume":"2015","author":"Jo","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"6","key":"10.1016\/j.lfs.2021.119908_bb0480","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/pharmaceutics13060810","article-title":"Engineering genetic systems for treating mitochondrial diseases","volume":"13","author":"Jang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2021.119908_bb0485","doi-asserted-by":"crossref","first-page":"17277","DOI":"10.1038\/s41598-018-34909-3","article-title":"Development of a multi-locus CRISPR gene drive system in budding yeast","volume":"8","author":"Yan","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119908_bb0490","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10565-019-09489-1","article-title":"CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9","volume":"35","author":"Yan","year":"2019","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.lfs.2021.119908_bb0495","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41422-020-0290-0","article-title":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses","volume":"30","author":"Nguyen","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2021.119908_bb0500","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-020-02355-3","article-title":"SARS-CoV-2 RNA polymerase as target for antiviral therapy","volume":"18","author":"Buonaguro","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2021.119908_bb0505","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.119908_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.576875","article-title":"CRISPR-cas system: an approach with potentials for COVID-19 diagnosis and therapeutics","volume":"10","author":"Kumar","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100895X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100895X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:10:20Z","timestamp":1762211420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052100895X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":102,"alternative-id":["S002432052100895X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119908","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of CRISPR as a potential therapeutic","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119908"}}